Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gough

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 21, 2002
Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazoneJ R Herman, L A Dethloff, E J McGuire, et al.
Virology|October 14, 2003
Therapeutic immunisation with COPV early genes by epithelial DNA deliveryRichard A Moore, Sarah Walcott, Kate L White, et al.
Toxicology and Applied Pharmacology|April 13, 1999
p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazoneS K Duddy, R F Parker, M R Bleavins, et al.
Virology|December 31, 2002
Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beaglesRichard A Moore, Elmer B Santos, Philip K Nicholls, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 21, 2002
Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazoneJ R Herman, L A Dethloff, E J McGuire, et al.
Virology|October 14, 2003
Therapeutic immunisation with COPV early genes by epithelial DNA deliveryRichard A Moore, Sarah Walcott, Kate L White, et al.
Toxicology and Applied Pharmacology|April 13, 1999
p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazoneS K Duddy, R F Parker, M R Bleavins, et al.
Virology|December 31, 2002
Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beaglesRichard A Moore, Elmer B Santos, Philip K Nicholls, et al.
Pageof 7